Alkem Laboratories Gains 1.49%: 3 Key Factors Driving the Week’s Momentum

Monday, 20 July 2026: Upgrade Spurs Initial Gains

Alkem Laboratories began the week on a positive note, closing at Rs.5,656.55, up 1.87% from the previous Friday’s close of Rs.5,552.90. This rise coincided with MarketsMOJO’s upgrade of the stock from a Sell to a Hold rating, reflecting improved technical indicators and a fairer valuation despite recent financial challenges. The upgrade was underpinned by bullish weekly MACD and Bollinger Bands, signalling emerging upward momentum. The stock traded near its 52-week high of Rs.5,933.00, supported by a Mojo Score of 54.0, indicating a balanced outlook. Meanwhile, the Sensex remained flat, closing marginally down by 0.00%, highlighting Alkem’s relative strength.

Tuesday, 21 July 2026: Continued Momentum Amid Sector Stability

On 21 July, Alkem’s stock price advanced further to Rs.5,682.30, a 0.46% gain, maintaining its position near recent highs. The broader market was stable, with the Sensex edging up 0.04%. The upgrade’s positive sentiment appeared to sustain investor interest, although volume declined to 1,765 shares, suggesting cautious participation. The stock’s valuation metrics, including a PE ratio of 27.99 and ROCE of 19.58%, supported the Hold rating. This day marked the week’s peak closing price, reinforcing the technical strength noted earlier.

Wednesday, 22 July 2026: Profit Taking and Market Weakness

Midweek saw a reversal as Alkem’s price dropped 1.65% to Rs.5,588.75, reflecting profit-taking amid a broader market sell-off. The Sensex declined sharply by 0.88%, closing at 36,196.43, pressured by sectoral and macroeconomic concerns. Volume surged to 6,108 shares, indicating active trading but with bearish undertones. Despite this setback, the stock remained above key moving averages, suggesting underlying medium-term support. The decline also coincided with a sharp fall in delivery volumes, signalling reduced conviction among long-term holders.

Thursday, 23 July 2026: Open Interest Surge Amid Mixed Signals

Alkem Laboratories experienced a significant 14.97% increase in open interest in its derivatives segment, rising to 20,387 contracts from 17,733 the previous day. This surge indicated heightened market activity and repositioning among traders. Despite this, the stock’s price closed at Rs.5,606.50, a modest 0.32% gain, underperforming the Pharmaceuticals & Biotechnology sector’s 0.45% rise and contrasting with the Sensex’s 0.70% decline. Volume was moderate at 2,047 shares, while delivery volumes fell sharply by 70.71%, suggesting speculative trading in derivatives rather than strong cash market conviction. The stock traded above its 20-, 50-, 100-, and 200-day moving averages but below its 5-day average, signalling short-term consolidation amid a positive medium-term trend.

Friday, 24 July 2026: Continued Derivatives Interest and Weekly Close

On the final trading day of the week, Alkem’s derivatives open interest surged further by 17.13% to 20,197 contracts, accompanied by a futures volume of 11,455 contracts. The underlying equity price closed at Rs.5,635.60, up 0.52%, outperforming the sector’s decline of 0.51% and the Sensex’s fall of 0.32%. This marked a two-day consecutive gain streak, delivering a cumulative 0.43% return. However, delivery volumes remained subdued, down 41.06%, indicating limited long-term investor participation. The stock’s trading above key moving averages reinforced a cautiously optimistic technical outlook. The week ended with Alkem outperforming the Sensex by 3.34%, reflecting resilience amid broader market weakness.

Key Takeaways

Positive Signals: The MarketsMOJO upgrade to Hold on 20 July was a pivotal event, reflecting improved technical momentum and fair valuation metrics despite recent financial softness. The stock’s ability to close the week with a 1.49% gain while the Sensex declined 1.85% underscores its relative strength. Sustained trading above key moving averages and a rising Mojo Score of 54.0 support a cautiously optimistic outlook. The sharp increases in derivatives open interest on 23 and 24 July indicate growing market interest and potential for increased volatility or directional moves.

Cautionary Notes: Despite positive technical signals, the stock experienced a midweek dip amid broader market weakness and profit-taking. Delivery volumes declined sharply, signalling reduced conviction among long-term investors and a shift towards speculative derivatives trading. The stock’s valuation, with a PE ratio near 28 and a PEG of 2.43, suggests it is fairly priced but not undervalued. The recent reduction in promoter shareholding and modest operating profit growth remain areas to monitor for sustained fundamental improvement.

Conclusion

Alkem Laboratories Ltd demonstrated resilience during a volatile week, outperforming the Sensex by 3.34% and maintaining technical strength amid mixed volume and market signals. The upgrade to a Hold rating by MarketsMOJO, combined with surging derivatives open interest, reflects a market cautiously positioning for potential upside while remaining mindful of fundamental challenges. Investors should weigh the improving technical outlook against subdued delivery volumes and recent financial trends. Continued monitoring of price action, open interest, and sector developments will be essential to assess the sustainability of this momentum going forward.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today